Cepheid Wins $3.3M NIAID Grant to Further Develop PCR-Based TB Dx | GenomeWeb
NEW YORK (GenomeWeb News) – Cepheid today said it has received a $3.3-million Small Business Technology Transfer grant from the National Institute of Allergy and Infectious Disease to further develop its Mycobacterium tuberculosis diagnostic.
 
Cepheid and academic partners at the University of Medicine and Dentistry of New Jersey have worked together to develop a PCR cartridge that can detect M. tuberculosis and predict its resistance to drugs in about one hour.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.